Language selection

Government of Canada

Search

Details for: VIADERM KC

Company: TARO PHARMACEUTICALS INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
00717002VIADERM KC CRMTRIAMCINOLONE ACETONIDE; NEOMYCIN (NEOMYCIN SULFATE); GRAMICIDIN; NYSTATIN1 MG / G; 2.5 MG / G; 0.25 MG / G; 100000 UNIT / GCREAMTOPICAL
00717029VIADERM KC ONTTRIAMCINOLONE ACETONIDE; NEOMYCIN (NEOMYCIN SULFATE); GRAMICIDIN; NYSTATIN1 MG / G; 2.5 MG / G; 0.25 MG / G; 100000 UNIT / GOINTMENTTOPICAL
Search Reported Side Effects Report a Side Effect

Consumer Information

This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.

What the medication is used for

Viaderm K.C.® (Triamcinolone Acetonide, Nystatin, Neomycin Sulfate, and Gramicidin) is used to provide relief from the itching, burning, and swelling caused by bacterial and/or fungal infections.

Viaderm K.C. ® Cream and Viaderm K.C. ® Ointment contain antibacterial ingredients called gramicidin and neomycin, and should be used exactly as directed by your health care professional.

How to take Viaderm K.C.®?
Misuse or overuse of Viaderm K.C. ® Cream and Viaderm K.C. ® Ointment could lead to the growth of bacteria that will not be killed by gramicidin and/or neomycin (resistance). This means that Viaderm K.C. ® Cream and Viaderm K.C. ® Ointment or other medicines that contain gramicidin and/or neomycin may not work for you in the future.

Do not share your medicine.

What it does

Viaderm K.C.® is antibacterial and antifungal which destroy the bacteria and fungi (yeasts) causing the skin infections.

When it should not be used
  • if you are allergic to Triamcinolone Acetonide, Nystatin, Neomycin Sulfate, and Gramicidin or any of its non-medicinal ingredients (See What are the ingredients of Viaderm K.C. ®),
  • if you have primary skin infections,
  • if you have any serious skin lesions, most viral lesions of the skin (including chicken pox (varicella) cold sores or genital herpes (Herpes simplex)), and fungal skin lesions except caused by yeasts infections,
  • in your eyes,
  • in the outer area of your ear if you have an ear infection or holes in your eardrums (see p. 4), and
  • under covered skin dressing if you have skin swelling and infections
What the medicinal ingredient is

Triamcinolone Acetonide, Nystatin, Neomycin Sulfate, and Gramicidin

What the non-medicinal ingredients are

For cream: cetomacrogol emulsifying wax, citric acid, ethanol, methylparaben, mineral oil, perfume, propylparaben, propylene glycol, purified water, sodium phosphate dibasic, white petrolatum. For ointment: mineral oil, white petrolatum

What dosage form it comes in

Viaderm K.C.® Cream (Triamcinolone Acetonide 1 mg/g, Nystatin 100,000 units/g, Neomycin base (as sulphate) 2.5 mg/g, and Gramicidin 0.25 mg/g) is available in 15 g, 30 g, and 60 g tubes, and in 454 g jars.

Viaderm K.C.® Ointment (Triamcinolone Acetonide 1 mg/g, Nystatin 100,000 units/g, Neomycin base (as sulphate) 2.5 mg/g, and Gramicidin 0.25 mg/g) is available in 15 g and 30 g tubes.

Warnings and precautions

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Viaderm K.C.®. Talk about any health conditions or problems you may have, including:

  • your previous use of corticosteroids,
  • if your condition has not changed within 7days,
  • if you use it for large skin areas,
  • if you have skin lesions close to the eye, and
  • if you have allergic reactions such as burning, itching, irritation, dryness, and skin discoloration.

Other warnings you should know about

  • Avoid contact with the eyes. If accidental contact occurs, rinse the eyes thoroughly with water
  • If further skin irritation develops or the infection worsens, contact your doctor.
  • Avoid continuous or prolonged use as potential adverse effects increase with longer use.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Interactions with this medication

Drug interactions studies have not been done for Viaderm K.C.®

Proper use of this medication

Small quantity 2 or 3 times daily.

Usual dose

Apply a small amount to the affected area 2 or 3 times daily.
Do not apply to open wounds or burns to avoid absorption of the drug(s) into the blood.
Do not apply more than prescribed by the doctor. For external use only.

Overdose

If you think you have applied too much Viaderm K.C.®, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.
Side effects and what to do about them

What are possible side effects from using Viaderm K.C.®?

  • Skin reactions such as burning, itching, irritation, dryness, and skin discoloration.

These are not all the possible side effects you may feel when taking Viaderm K.C.®. If you experience any side effects not listed here, contact your healthcare professional. Please also see Warnings and Precautions.

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

How to store

Store at room temperature between 15ºC and 30ºC.
Keep out of reach and sight of children.

Reporting side effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

More information
  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website; the manufacturer’s website http://www.taro.ca, or by calling 1-800-268-1975.

This leaflet was prepared by Taro Pharmaceuticals Inc.
Last Revised: July 5, 2018

Date modified: